FDA Inspection
Lotte Biologics USA, LLCLotte Biologics USA, LLC – FDA Inspection, Jul 20, 2012
Record Details
This FDA Inspection record concerns Lotte Biologics USA, LLC, with an inspection on July 20, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lotte Biologics USA, LLC
- Inspection Date
- July 20, 2012
- Product Type
- Drugs
View Company Profile
ID · c2bfbf47-3810-4dd6-91b7-8b296dc37249
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 794472
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 111.325(a)Laboratory operations: electronic
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lotte Biologics USA, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2026 | Not classified | New York District Office | |
| September 19, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 5, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lotte Biologics USA, LLC
- FDA Inspection 1341414 - 2026-09-18
- FDA Inspection 1246771 - 2024-09-19
- FDA Inspection 1093554 - 2019-06-05
- FDA Inspection 1010187 - 2017-04-28
- FDA Inspection 897857 - 2014-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.